View in EDS

Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.

Saved in:
Bibliographic Details
Title: Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.
Authors: Mancini GBJ; Centre for Cardiovascular Innovation, Dilawri Cardiovascular Institute, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: mancini@mail.ubc.ca., Ryomoto A; Centre for Cardiovascular Innovation, Dilawri Cardiovascular Institute, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada., Ruel I; Research Institute of the McGill University Health Center, Department of Medicine, Montreal, Quebec, Canada., Iatan I; Research Institute of the McGill University Health Center, Department of Medicine, Montreal, Quebec, Canada; Centre for Heart and Lung Innovation, Division of General Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Genest J; Research Institute of the McGill University Health Center, Department of Medicine, Montreal, Quebec, Canada., Raal FJ; Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Santos RD; Academic Research Organization, Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Lipid Clinic, Heart Institute (InCor) University of Sao Paulo, Medical School Hospital, Sao Paulo, Brazil., Marte AP; Lipid Clinic, Heart Institute (InCor) University of Sao Paulo, Medical School Hospital, Sao Paulo, Brazil., Kennedy BA; Departments of Medicine and Biochemistry, Robarts Research Institute, University of Western Ontario, London, Ontario Canada., Brunham LR; Centre for Heart and Lung Innovation, Division of General Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Gaudet D; Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, Canada., Larouche M; Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, Canada., Brisson D; Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, Canada., Hegele RA; Departments of Medicine and Biochemistry, Robarts Research Institute, University of Western Ontario, London, Ontario Canada.
Corporate Authors: Canadian Homozygous Familial Hypercholesterolemia - HoFH Registry
Source: Atherosclerosis [Atherosclerosis] 2026 Mar; Vol. 414, pp. 120646. Date of Electronic Publication: 2026 Jan 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484 (Electronic) Linking ISSN: 00219150 NLM ISO Abbreviation: Atherosclerosis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41643340
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mancini+GBJ%22">Mancini GBJ</searchLink>; Centre for Cardiovascular Innovation, Dilawri Cardiovascular Institute, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: mancini@mail.ubc.ca.<br /><searchLink fieldCode="AU" term="%22Ryomoto+A%22">Ryomoto A</searchLink>; Centre for Cardiovascular Innovation, Dilawri Cardiovascular Institute, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Ruel+I%22">Ruel I</searchLink>; Research Institute of the McGill University Health Center, Department of Medicine, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Iatan+I%22">Iatan I</searchLink>; Research Institute of the McGill University Health Center, Department of Medicine, Montreal, Quebec, Canada; Centre for Heart and Lung Innovation, Division of General Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Genest+J%22">Genest J</searchLink>; Research Institute of the McGill University Health Center, Department of Medicine, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Raal+FJ%22">Raal FJ</searchLink>; Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Santos+RD%22">Santos RD</searchLink>; Academic Research Organization, Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Lipid Clinic, Heart Institute (InCor) University of Sao Paulo, Medical School Hospital, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Marte+AP%22">Marte AP</searchLink>; Lipid Clinic, Heart Institute (InCor) University of Sao Paulo, Medical School Hospital, Sao Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Kennedy+BA%22">Kennedy BA</searchLink>; Departments of Medicine and Biochemistry, Robarts Research Institute, University of Western Ontario, London, Ontario Canada.<br /><searchLink fieldCode="AU" term="%22Brunham+LR%22">Brunham LR</searchLink>; Centre for Heart and Lung Innovation, Division of General Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Gaudet+D%22">Gaudet D</searchLink>; Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Larouche+M%22">Larouche M</searchLink>; Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Brisson+D%22">Brisson D</searchLink>; Department of Medicine and ECOGENE-21, Université de Montreal, Chicoutimi, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Hegele+RA%22">Hegele RA</searchLink>; Departments of Medicine and Biochemistry, Robarts Research Institute, University of Western Ontario, London, Ontario Canada.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Canadian+Homozygous+Familial+Hypercholesterolemia+-+HoFH+Registry%22">Canadian Homozygous Familial Hypercholesterolemia - HoFH Registry</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220242543%22">Atherosclerosis</searchLink> [Atherosclerosis] 2026 Mar; Vol. 414, pp. 120646. <i>Date of Electronic Publication: </i>2026 Jan 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>0242543 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-1484 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219150%22">00219150 </searchLink><i>NLM ISO Abbreviation: </i>Atherosclerosis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41643340
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.atherosclerosis.2026.120646
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 120646
    Titles:
      – TitleFull: Assessment of LDL receptor-dependent lipid lowering therapies in patients with homozygous familial hypercholesterolemia according to functional genotype.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mancini GBJ
      – PersonEntity:
          Name:
            NameFull: Ryomoto A
      – PersonEntity:
          Name:
            NameFull: Ruel I
      – PersonEntity:
          Name:
            NameFull: Iatan I
      – PersonEntity:
          Name:
            NameFull: Genest J
      – PersonEntity:
          Name:
            NameFull: Raal FJ
      – PersonEntity:
          Name:
            NameFull: Santos RD
      – PersonEntity:
          Name:
            NameFull: Marte AP
      – PersonEntity:
          Name:
            NameFull: Kennedy BA
      – PersonEntity:
          Name:
            NameFull: Brunham LR
      – PersonEntity:
          Name:
            NameFull: Gaudet D
      – PersonEntity:
          Name:
            NameFull: Larouche M
      – PersonEntity:
          Name:
            NameFull: Brisson D
      – PersonEntity:
          Name:
            NameFull: Hegele RA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-1484
          Numbering:
            – Type: volume
              Value: 414
          Titles:
            – TitleFull: Atherosclerosis
              Type: main
ResultId 1